Ocugen is a biopharmaceutical company based in Malvern, PA, specializing in the development and commercialization of innovative gene therapies to treat rare and underserved eye diseases.
With a focus on advancing cutting-edge research and technology, Ocugen aims to provide novel treatment options for patients in need of effective and sustainable solutions for their ocular health conditions.
Generated from their business information